Skip to content

Clinical Study for Treatment of Acute Ischemic Stroke

Clinical Study for Thrombolysis and Thrombolysis for Acute Ischemic Stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900020786
Enrollment
Unknown
Registered
2019-01-19
Start date
2019-04-01
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

Experimental group:mechanical thrombectomy
Control group:Intravenous thrombolysis

Sponsors

Affiliated Hospital of Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged at least 18 years old; 2. Ischemic stroke was clearly diagnosed clinically and caused definite neurological dysfunction (NIHSS score > 4), no coma, and the symptoms and signs of brain function damage existed for more than 1 hour, and no significant improvement was observed before treatment; 3. Within 4.5 hours or 6 hours of onset; 4. Informed consent and signature of the patient or his family members on the benefit/risk of thrombolysis. Inclusion criteria for thrombectomy: 1. Age older than 18 years; 2. Preoperative CTASPECTS score greater than 6 points; 3. Ischemic stroke caused by macrovascular occlusion; 4. Informed consent of patients.

Exclusion criteria

Exclusion criteria: Thrombolytic exclusion criteria: 1. Neurological dysfunction is very mild or rapidly improved; 2. The onset of the disease is beyond the time window or uncertain. 3. With definite epileptic seizures; 4. Cranial CT examination revealed intracranial hemorrhage, brain edema, space-occupying effect, tumors and arteriovenous malformations; clinical manifestations of subarachnoid hemorrhage (even if CT showed normal); CT showed low density > 1/3 middle cerebral artery blood supply area (patients with cerebral infarction in middle cerebral artery); 5. Previous intracranial hemorrhage, including suspicious subarachnoid hemorrhage; intracranial surgery, cranial trauma, stroke and myocardial infarction in recent 3 months; active bleeding of visceral organs such as digestive tract and urinary system in recent 3 weeks; surgical operation in recent 2 weeks; lumbar puncture or arterial puncture in recent 1 week; 6. Physical examination found evidence of active hemorrhage or trauma (such as fracture). 7. Severe heart, liver and kidney dysfunction or severe diabetes mellitus; 8. Having blood disease, bleeding tendency, coagulation disorder, platelet count 1.5; 9. Blood sugar 180 mmHg or diastolic blood pressure > 100 mmHg, or need to actively reduce blood pressure to reach the required range; 10. Pregnant women. Exclusion criteria for thrombectomy; 1) patients with severe cardiopulmonary insufficiency; 2) patients with renal failure; 3) platelets below 50*10^9.

Design outcomes

Primary

MeasureTime frame
Three-month follow-up mRS;

Countries

China

Contacts

Public ContactYuan Zhengzhou

Affiliated Hospital of Southwest Medical University

bibiyou@163.com+86 0830 3165661

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026